公开(公告)号：US08319469B2

公开(公告)日：2012-11-27

申请号：US13299667

申请日：2011-11-18

Applicant: Keshatoshi Takeuchi ,  Mamoru Sugimoto ,  Yojiro Okakura

Inventor： Keshatoshi Takeuchi ,  Mamoru Sugimoto ,  Yojiro Okakura

IPC: H02K41/00

CPC classification number: H02K29/08 ,  B60L3/0061 ,  B60L7/14 ,  B60L11/007 ,  B60L11/1803 ,  B60L15/007 ,  B60L15/20 ,  B60L2200/12 ,  B60L2220/14 ,  B60L2220/16 ,  B60L2220/44 ,  B60L2220/50 ,  H02K1/02 ,  H02K3/02 ,  H02K5/08 ,  H02K21/24 ,  Y02T10/641 ,  Y02T10/645 ,  Y02T10/7005 ,  Y02T10/72 ,  Y02T10/7275

Abstract: The brushless electric machine includes a first drive member (30U) having a plurality of permanent magnets (32U); a second drive member (10) having a plurality of electromagnetic coils and capable of movement relative to the first drive member (30U); and a third drive member (30L) disposed at the opposite side from the first drive member (30U) with the second drive member (10) therebetween. The second drive member (10) has magnetic sensors (40A, 40B) for detecting the relative position of the first and second drive members. The third drive member (30L) has at locations facing the permanent magnets of the first drive member (30U) a plurality of magnetic field strengthening members (32L) for strengthening the magnetic field at the location of the second drive member (10) in conjunction with the permanent magnets.

Abstract translation: 无刷电机包括具有多个永磁体（32U）的第一驱动部件（30U）。 具有多个电磁线圈并能够相对于第一驱动构件（30U）移动的第二驱动构件（10）; 以及第三驱动构件（30L），其与第一驱动构件（30U）的相对侧设置有第二驱动构件（10）。 第二驱动构件（10）具有用于检测第一和第二驱动构件的相对位置的磁传感器（40A，40B）。 第三驱动构件（30L）在与第一驱动构件（30U）的永磁体相对的位置处具有用于在第二驱动构件（10）的位置处加强磁场的多个磁场强化构件（32L） 与永磁体。

公开(公告)号：US06337390B1

公开(公告)日：2002-01-08

申请号：US09180618

申请日：1999-01-19

Applicant: Shuji Fujita ,  Masaaki Numata ,  Kazuo Suzuki ,  Shigeki Nunomura ,  Mamoru Sugimoto ,  Masaki Terada

Inventor： Shuji Fujita ,  Masaaki Numata ,  Kazuo Suzuki ,  Shigeki Nunomura ,  Mamoru Sugimoto ,  Masaki Terada

IPC: C07H1500

CPC classification number: C07H15/06 ,  C07H15/04 ,  C07H15/10 ,  C07H15/14 ,  C07H15/203 ,  Y10S514/934

Abstract: In order to provide the anti-retrovirus active compound with low anti-coagulant action and low cytotoxicity, compounds comprising glycoside or the salt thereof wherein lipid is linked to position 2 of sialic acid having all hydroxyl groups at positions 4, 7, 8 and 9 completely sulfated, or KDN (2-keto-3-deoxy-D-glycero-2-nononic acid) having all hydroxyl groups at positions 4, 5, 7, 8 and 9 completely sulfated are provided.

Abstract translation: 为了提供具有低抗凝血作用和低细胞毒性的抗逆转录病毒活性化合物，包含糖苷或其盐的化合物，其中脂质连接到位于第4,7,8和9位具有所有羟基的唾液酸的位置2 或完全硫酸化的第4,5,7,8和9位具有全羟基的KDN（2-酮-3-脱氧-D-甘油-2-壬二酸）完全硫酸化。

公开(公告)号：US6113848A

公开(公告)日：2000-09-05

申请号：US141734

申请日：1998-08-27

Applicant: Mamoru Sugimoto ,  Jiro Tanaka

Inventor： Mamoru Sugimoto ,  Jiro Tanaka

IPC: B21K1/30 ,  B22F3/02 ,  B22F3/035 ,  B22F5/08 ,  B30B11/02 ,  C22C33/02

CPC classification number: B22F5/085 ,  B21K1/30 ,  B22F5/08 ,  B30B11/02 ,  B30B11/027 ,  B22F2998/00 ,  Y10S425/058

Abstract: A spiral helical gear having right and left tooth flanks having such a small pitch angle that either right or left ones are not seen in plan from the apex side of cone is molded by a powder molding device so as not to interfere with a die of the device when removed from the die. The die has teeth for molding and is rotatably supported. A fixed guide mechanism for guiding the die is provided. Guide portions of the guide mechanism have a predetermined lead so that the die is rotated guided by the guide portions when the molded article is punched out of the die. Thus, the teeth formed on the molded article reliably disengage from the teeth for molding. This makes it possible to reliably punch the molded article out of the die.

Abstract translation: 具有左右齿面的螺旋斜齿轮由粉末成型装置模制而成，具有如右侧或左侧所示的左右齿面从锥体的顶端侧看不到平面的左右齿面，以免与 设备从模具中取出时。 模具具有用于模制的齿并被可旋转地支撑。 提供了用于引导模具的固定引导机构。 引导机构的引导部分具有预定的引线，使得当模制品冲压出模具时，模具被引导部分引导。 因此，形成在模制品上的齿可以与用于模制的齿可靠地脱开。 这使得可以将模制品可靠地冲压出模具。

公开(公告)号：US5763413A

公开(公告)日：1998-06-09

申请号：US505352

申请日：1995-08-30

Applicant: Masaaki Numata ,  Shigeki Nunomura ,  Shuji Fujita ,  Masami Iida ,  Akira Endo ,  Takayuki Ishii ,  Tomoya Ogawa ,  Mamoru Sugimoto ,  Ryoichi Osawa ,  Masamichi Fujita

Inventor： Masaaki Numata ,  Shigeki Nunomura ,  Shuji Fujita ,  Masami Iida ,  Akira Endo ,  Takayuki Ishii ,  Tomoya Ogawa ,  Mamoru Sugimoto ,  Ryoichi Osawa ,  Masamichi Fujita

IPC: C07H3/06 ,  C07H13/04 ,  C07H15/04 ,  C07H15/10 ,  A61K31/70 ,  C07H15/00 ,  C07H17/00

CPC classification number: C07H13/04 ,  C07H15/04 ,  C07H15/10 ,  C07H3/06

Abstract: A Lewis-associated compound, represented by general formula (I), a process for producing the same, and an anti-inflammatory, wherein R.sup.1 and R.sup.3 represent each hydrogen, m SO.sub.3 H or CH.sub.2 COOH; R.sup.2 represents hydrogen, SO.sub.3 H, CH.sub.2 COOH or N-acetyl-neutraminic acid residue; R.sup.4 represents hydrogen; R.sup.5 represents O-lower alkyl, O-lower alkenyl, O-ceramide residue, O-mannose residue, O-galactose residue or O-lactose residue; R.sup.6 represents acetylamine; and R.sup.7 and R.sup.8 represent each hydrogen. ##STR1##

Abstract translation: PCT No.PCT / JP94 / 00352 Sec。 371日期：1995年8月30日 102（e）日期1995年8月30日PCT 1994年3月4日PCT公布。 第WO94 / 20514号公报 1994年9月15日由通式（I）表示的路易斯相关化合物，其制造方法和抗炎剂，其中，R 1和R 3表示各自的氢，m SO 3 H或CH 2 COOH; R2表示氢，SO3H，CH2COOH或N-乙酰基 - 中甲酰赖氨酸残基; R4代表氢; R5表示O-低级烷基，O-低级烯基，O-神经酰胺残基，O-甘露糖残基，O-半乳糖残基或O-乳糖残基; R6表示乙酰胺; 并且R7和R8表示每个氢。 （一）

公开(公告)号：US5668115A

公开(公告)日：1997-09-16

申请号：US450699

申请日：1995-05-25

Applicant: Ryoichi Osawa ,  Isao Suda ,  Masaaki Numata ,  Mamoru Sugimoto ,  Kenkichi Tomita ,  Nobuyuki Kibushi ,  Takayuki Ishii ,  Naokazu Sugiyama ,  Makiko Kasano ,  Tae Yasunaga ,  Makoto Tanaka ,  Tomoya Ogawa ,  Mariko Ishii

Inventor： Ryoichi Osawa ,  Isao Suda ,  Masaaki Numata ,  Mamoru Sugimoto ,  Kenkichi Tomita ,  Nobuyuki Kibushi ,  Takayuki Ishii ,  Naokazu Sugiyama ,  Makiko Kasano ,  Tae Yasunaga ,  Makoto Tanaka ,  Tomoya Ogawa ,  Mariko Ishii

IPC: C12P19/04 ,  A61K31/70 ,  A61K31/715 ,  A61P7/02 ,  A61P13/02 ,  A61P15/00 ,  A61P37/08 ,  C07H13/04 ,  C12R1/01

CPC classification number: A61K31/715 ,  A61K31/70 ,  A61K31/7012 ,  A61K31/7016 ,  A61K31/702 ,  C07H13/04 ,  Y10S514/825 ,  Y10S514/885

Abstract: An anti-inflammatory drug comprising as the effective component at least one compound selected from the group consisting of colominic acid, partial hydrolysis products of colominic acid and pharmaceutically acceptable salts thereof. The drug is used as a drug for renal diseases, a drug for hepatitis, an immunomodulator and a drug for inhibiting the chemotaxis of neutrophil.

Abstract translation: 一种抗炎药，其包含选自科洛芬酸，聚洛米酸的部分水解产物和其药学上可接受的盐中的至少一种化合物作为有效成分。 该药用作肾脏疾病的药物，用于肝炎的药物，免疫调节剂和抑制嗜中性粒细胞趋化性的药物。

公开(公告)号：US5529854A

公开(公告)日：1996-06-25

申请号：US231866

申请日：1994-04-25

Applicant: Tatsuya Shimoda ,  Satoshi Shimokawato ,  Shin Funada ,  Mamoru Sugimoto ,  Akira Aoyama ,  Satoshi Nebashi

Inventor： Tatsuya Shimoda ,  Satoshi Shimokawato ,  Shin Funada ,  Mamoru Sugimoto ,  Akira Aoyama ,  Satoshi Nebashi

IPC: G11B11/105 ,  G11B5/66 ,  C23C14/00 ,  G11B11/00 ,  G11C13/06

CPC classification number: G11B11/10582 ,  G11B11/10586 ,  Y10S428/90

Abstract: A magnetic recording film and a magneto-optic recording system utilizing films. The film includes light and heavy rare earth elements and transition metal elements. The system can include dielectric layers and low magnetic coercivity layers in addition to the recording layer.

Abstract translation: 磁记录膜和利用膜的磁光记录系统。 该薄膜包括轻和重稀土元素和过渡金属元素。 该系统除了记录层之外还可以包括电介质层和低磁矫顽力层。

公开(公告)号：US5504735A

公开(公告)日：1996-04-02

申请号：US163604

申请日：1993-12-06

Applicant: Tsutomu Ota ,  Mamoru Sugimoto ,  Yasuto Nose ,  Hidetoshi Yoshitaki ,  Tatsuro Higashi ,  Takashi Hayashi

Inventor： Tsutomu Ota ,  Mamoru Sugimoto ,  Yasuto Nose ,  Hidetoshi Yoshitaki ,  Tatsuro Higashi ,  Takashi Hayashi

IPC: G11B7/24 ,  G11B23/00 ,  G11B3/70

CPC classification number: G11B23/0035 ,  G11B7/24

Abstract: An information recording disk formed from two substrates with a stepped central opening for receiving a hub within the stepped recess of at least one of the substrates is provided. In one embodiment, the central aperture of the first substrate is larger than the central aperture of the second substrate to form the stepped recess. In another embodiment, at least one substrate has a stepped surface defining a central aperture and a hub structure is mounted within this stepped recess to reduce overall thickness of the disk.

Abstract translation: 提供了一种信息记录盘，其由具有台阶中心开口的两个基板形成，用于在至少一个基板的台阶凹槽内容纳轮毂。 在一个实施例中，第一基板的中心孔径大于第二基板的中心孔径以形成台阶凹槽。 在另一个实施例中，至少一个基板具有限定中心孔的台阶表面，并且毂结构安装在该阶梯形凹槽内以减小盘的整体厚度。

公开(公告)号：US5393742A

公开(公告)日：1995-02-28

申请号：US109614

申请日：1993-08-19

Applicant: Takayuki Ishii ,  Makiko Kasano ,  Tae Yasunaga ,  Mariko Ishii ,  Mamoru Sugimoto ,  Kenkichi Tomita ,  Takeshi Miyata ,  Makoto Tanaka

Inventor： Takayuki Ishii ,  Makiko Kasano ,  Tae Yasunaga ,  Mariko Ishii ,  Mamoru Sugimoto ,  Kenkichi Tomita ,  Takeshi Miyata ,  Makoto Tanaka

IPC: A61K31/70

CPC classification number: A61K31/7004 ,  A61K31/70

Abstract: A preparation is useful for treating renal disease, such as nephritis and especially nephrosis (nephrotic syndrome), which comprises an effective amount of N-acetylneuraminic acid shown by the formula ##STR1## wherein, when n is 1, Z represents hydrogens, lithium, potassium, sodium, ammonium or organic ammonium, and when n is 2, Z represents calcium, barium or magnesium, and a pharmacologically acceptable carrier.

Abstract translation: 一种制剂可用于治疗肾脏疾病，例如肾炎，特别是肾病（肾病综合征），其包含有效量的由马来酰亚胺，锂，钾，钠，铵或有机铵显示的N-乙酰神经氨酸，当n为 2，Z表示钙，钡或镁，以及药理学上可接受的载体。

公开(公告)号：US5264567A

公开(公告)日：1993-11-23

申请号：US13993

申请日：1993-02-05

Applicant: Masaaki Numata ,  Mamoru Sugimoto ,  Shuji Fujita ,  Masanori Kobayashiu ,  Kenkichi Tomita ,  Makoto Tanaka ,  Tomoya Ogawa

Inventor： Masaaki Numata ,  Mamoru Sugimoto ,  Shuji Fujita ,  Masanori Kobayashiu ,  Kenkichi Tomita ,  Makoto Tanaka ,  Tomoya Ogawa

IPC: C07H13/04 ,  C07H15/04 ,  C07H15/10 ,  C07H15/14 ,  C07G17/00 ,  A01N43/04 ,  C07H1/00 ,  C07H5/04

CPC classification number: C07H13/04 ,  C07H15/04 ,  C07H15/10 ,  C07H15/14

Abstract: GM.sub.3 analogous compound (I) below: ##STR1## wherein one of R.sup.2 and R.sup.3 represents a neuramic acid group represented by general formula (V): ##STR2## R.sup.5 represents ##STR3## or hydrogen; R.sup.6 represents hydrogen or a ceramide group represented by general formula (VI): ##STR4##

Abstract translation: GM3类似化合物（I）：其中R2和R3之一表示由通式（V）表示的神经酰胺酸基团：其中R5表示氢或氢; R6表示氢或由通式（VI）表示的神经酰胺基团：（VI）

公开(公告)号：US5101026A

公开(公告)日：1992-03-31

申请号：US82289

申请日：1987-08-06

Applicant: Tomoya Ogawa ,  Mamoru Sugimoto ,  Masaaki Numata ,  Masayoshi Ito ,  Yoshiyasu Shitori ,  Shigeki Nunomura

Inventor： Tomoya Ogawa ,  Mamoru Sugimoto ,  Masaaki Numata ,  Masayoshi Ito ,  Yoshiyasu Shitori ,  Shigeki Nunomura

IPC: C07H3/06 ,  C07H15/10

CPC classification number: C07H15/10 ,  C07H3/06

Abstract: The present invention relates to ganglioside related compounds having, for example, the following formula: ##STR1## where R.sub.1 represents H or COCH.sub.3 (hereinafter abbreviated to "AC"); R.sub.2 represents H or CH.sub.3 ; and R.sub.3 represents --OH, ##STR2## These ganglioside related compounds are useful as membrane receptors, tumor markers, cell growth controlling substances, etc., and useful for immunotherapy for cancer, etc.